Inhibition of iRhom1 and thereby blocking subsequent ADAM17‐mediated shedding of CD44, enhanced tumor uptake of CD44 directed chemotherapeutics and increased tumor clearance in multiple cancers in mice (Luo et al. 2024). This evidence concerns the gene ADAM17 and neoplasm.